The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGresham Regulatory News (GHT)

Share Price Information for Gresham (GHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.00
Bid: 162.00
Ask: 164.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.235%)
Open: 163.00
High: 163.00
Low: 163.00
Prev. Close: 163.00
GHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 May 2017 16:39

RNS Number : 6498E
Gresham Technologies PLC
09 May 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Gresham Technologies PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Kestrel Partners LLP

4. Full name of shareholder(s)  (if different from 3.):iv

Kestrel Opportunities, a cell of Guernsey Portfolios PCC Ltd (through BNY Mellon Nominees Limited) and various other clients of Kestrel Partners LLP (through JIM Nominees Ltd and Bank of New York Nominees Ltd)

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

05 May 2017

6. Date on which issuer notified:

09 May 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

through 15%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 5p each

ISIN GB0008808825

10,086,137

10,086,137

n/a

n/a

10,148,137

n/a

15.09%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

n/a

n/a

n/a

n/a

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

n/a

n/a

n/a

n/a

n/a

Nominal

Delta

n/a

n/a

Total (A+B+C)

Number of voting rights

Percentage of voting rights

10,148,137

15.09%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Indirect - Bank of New York Nominees Limited - 8,811,932 Shares. 13.10% of voting rights

Indirect - JIM Nominees Limited - 392,783 Shares. 0.59% of voting rights

Indirect - Bank of New York Nominees Limited - 943,422 Shares. 1.40% of voting rights

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Disclosure based on Total voting rights of 67,272,018.

The indirect voting rights held under (9) relate to shares held in client portfolios managed by Kestrel Partners LLP under discretionary investment management agreements

14. Contact name:

Ian Forrest

15. Contact telephone number:

0203 371 6100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSSEFIUFWSEDI
Date   Source Headline
4th Mar 20207:00 amRNSNotice of Results & Analyst Presentation
3rd Feb 20207:00 amRNSElectronic Communications
28th Jan 20203:13 pmRNSHolding(s) in Company
6th Jan 20207:00 amRNSTrading Update
3rd Jan 20201:27 pmRNSHolding(s) in Company
27th Dec 20192:55 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSClareti Contract Win and Trading Update
25th Sep 20197:00 amRNSExercise of Options
20th Sep 20197:00 amRNSGresham and ANZ partnership
2nd Sep 201911:11 amRNSHolding(s) in Company
2nd Aug 20195:46 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNotice of Results & Analyst Presentation
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSStrategic fintech partner signs Clareti agreement
5th Jun 20199:56 amRNSHolding(s) in Company
30th May 20197:00 amRNSSignificant Clareti Contract
2nd May 20193:42 pmRNSResult of AGM
2nd May 20197:00 amRNSAGM Statement
26th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSDirector's Dealing
4th Apr 20197:00 amRNSExercise of Options
29th Mar 20197:00 amRNSGrant of Options
28th Mar 20197:00 amRNSDirector's Dealing
27th Mar 20197:01 amRNSSignificant Clareti Contract with Tier 1 Bank
27th Mar 20197:00 amRNSNotice of AGM and Dividend Timetable
12th Mar 20197:00 amRNSFinal Results
7th Mar 201910:00 amRNSNotice of Results
7th Mar 20197:00 amRNSStrategic relationship with RegTek.Solutions
1st Feb 20197:00 amRNSSignificant Clareti Contract with Tier 1 Bank
29th Jan 201911:51 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSSale of VME mainframe software business
7th Jan 20193:45 pmRNSHolding(s) in Company
7th Jan 20193:45 pmRNSHolding(s) in Company
4th Jan 201912:00 pmRNSClareti Contract Signed & Trading Update
17th Dec 20187:00 amRNSExtension of Clareti innovation service
6th Dec 20187:00 amRNSTrading Update
10th Oct 20187:00 amRNSTrading Update
1st Oct 20183:01 pmRNSExercise of Options
26th Sep 20187:00 amRNSStrategic fintech partnership with major bank
4th Sep 20183:35 pmRNSHolding(s) in Company
27th Jul 20187:00 amRNSExercise of Options
24th Jul 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNotice of Results & Analyst Presentation
10th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 201811:05 amRNSSecond Price Monitoring Extn
4th Jul 201811:00 amRNSPrice Monitoring Extension
4th Jul 20187:01 amRNSAcquisition of B2 Group
4th Jul 20187:00 amRNSTrading Update
18th May 20185:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.